X
Xavier Forns
Researcher at University of Barcelona
Publications - 429
Citations - 25508
Xavier Forns is an academic researcher from University of Barcelona. The author has contributed to research in topics: Hepatitis C & Liver transplantation. The author has an hindex of 68, co-authored 382 publications receiving 23458 citations. Previous affiliations of Xavier Forns include National Institutes of Health & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
EASL Recommendations on Treatment of Hepatitis C
Jean-Michel Pawlotsky,Alessio Aghemo,Geoffrey Dusheiko,Xavier Forns,Massimo Puoti,Christophe Sarrazin +5 more
TL;DR: The optimal management of patients with acute and chronic HCV infections in 2018 and onwards is described, as well as developments in diagnostic procedures and improvements in therapy and prevention.
Journal ArticleDOI
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
C.P.G.P.P. Marcellin,G.M. Dusheiko,Fabien Zoulim,Rafael Esteban,Stephanos J. Hadziyannis,Pietro Lampertico,M.P. Manns,Daniel Shouval,Cihan Yurdaydin,R.A. Craxi,Xavier Forns,Darius Moradpour,Jean-Michel Pawlotsky,Jörg Petersen,H.W.F. Easl +14 more
TL;DR: The objective of these EASL Clinical Practice Guidelines is to update recommendations for the optimal management of chronic hepatitis B (CHB) and the CPGs do not focus on prevention and vaccination.
Journal ArticleDOI
Non-invasive evaluation of liver fibrosis using transient elastography ☆
TL;DR: TE appears to be an excellent tool for early detection of cirrhosis and may have prognostic value in this setting and could be useful for monitoring fibrosis progression and regression in the individual case, but more data are awaited for this application.
Journal ArticleDOI
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
Xavier Forns,Sergi Ampurdanés,Josep M. Llovet,John J. Aponte,Llorenç Quintó,Eva Martínez-Bauer,Miquel Bruguera,José María Sánchez-Tapias,Juan Rodés +8 more
TL;DR: A combination of easily accessible variables accurately predicts the absence of significant fibrosis and might render liver biopsy unnecessary in more than one third of patients with chronic hepatitis C.
Journal ArticleDOI
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig,Zoe Mariño,Christie Perelló,Mercedes Iñarrairaegui,Andrea Ribeiro,Sabela Lens,Alba Díaz,Ramón Vilana,Anna Darnell,Maria Varela,Bruno Sangro,Jose Luis Calleja,Xavier Forns,Jordi Bruix +13 more
TL;DR: The data show an unexpected high rate and pattern of tumor recurrence coinciding with HCV clearance and, although based in a very small cohort of patients, should be taken as a note of caution and prime a large scale assessment that exceeds the individual investigators capacity.